RJ, E., MJ, K., A, C., RP, S., N, A., & DL, K. (2017). ABCG2 regulatory single-nucleotide polymorphisms alter in vivo enhancer activity and expression. Pharmacogenetics and genomics, 27(12), 454. https://doi.org/10.1097/FPC.0000000000000312
Chicago Style (17th ed.) CitationRJ, Eclov, Kim MJ, Chhibber A, Smith RP, Ahituv N, and Kroetz DL. "ABCG2 Regulatory Single-nucleotide Polymorphisms Alter in Vivo Enhancer Activity and Expression." Pharmacogenetics and Genomics 27, no. 12 (2017): 454. https://doi.org/10.1097/FPC.0000000000000312.
MLA (9th ed.) CitationRJ, Eclov, et al. "ABCG2 Regulatory Single-nucleotide Polymorphisms Alter in Vivo Enhancer Activity and Expression." Pharmacogenetics and Genomics, vol. 27, no. 12, 2017, p. 454, https://doi.org/10.1097/FPC.0000000000000312.